Sequoia Capital China is raising $2.2 billion for a new yuan-denominated fund, the company's sixth fund. The company has invested in about 600 China companies in sectors that include TMT, healthcare, consumer/service, and industrial technology over the past 15 years. Sequoia China 's website lists 40 healthcare members of its portfolio, including Innovent, CStone, Zai Lab and Venus MedTech. The new fundraising is significant because it shows Sequoia, a US company, is committed to building its China business, despite rising diplomatic tensions between the two countries. More details... Share this with colleagues: // //